- Diseases
- Acoustic Neuroma (14)
- Adrenal Gland Tumor (24)
- Anal Cancer (68)
- Anemia (2)
- Appendix Cancer (16)
- Bile Duct Cancer (28)
- Bladder Cancer (68)
- Brain Metastases (28)
- Brain Tumor (236)
- Breast Cancer (714)
- Breast Implant-Associated Anaplastic Large Cell Lymphoma (2)
- Cancer of Unknown Primary (4)
- Carcinoid Tumor (8)
- Cervical Cancer (158)
- Colon Cancer (166)
- Colorectal Cancer (108)
- Endocrine Tumor (4)
- Esophageal Cancer (40)
- Eye Cancer (36)
- Fallopian Tube Cancer (6)
- Germ Cell Tumor (4)
- Gestational Trophoblastic Disease (2)
- Head and Neck Cancer (2)
- Kidney Cancer (124)
- Leukemia (352)
- Liver Cancer (50)
- Lung Cancer (290)
- Lymphoma (286)
- Mesothelioma (14)
- Metastasis (30)
- Multiple Myeloma (102)
- Myelodysplastic Syndrome (64)
- Myeloproliferative Neoplasm (4)
- Neuroendocrine Tumors (16)
- Oral Cancer (102)
- Ovarian Cancer (176)
- Pancreatic Cancer (172)
- Parathyroid Disease (2)
- Penile Cancer (16)
- Pituitary Tumor (6)
- Prostate Cancer (148)
- Rectal Cancer (58)
- Renal Medullary Carcinoma (6)
- Salivary Gland Cancer (14)
- Sarcoma (234)
- Skin Cancer (296)
- Skull Base Tumors (54)
- Spinal Tumor (12)
- Stomach Cancer (58)
- Testicular Cancer (28)
- Throat Cancer (92)
- Thymoma (6)
- Thyroid Cancer (98)
- Tonsil Cancer (32)
- Uterine Cancer (78)
- Vaginal Cancer (14)
- Vulvar Cancer (18)
- Cancer Topic
- Adolescent and Young Adult Cancer Issues (20)
- Advance Care Planning (8)
- Biostatistics (2)
- Blood Donation (18)
- Bone Health (8)
- COVID-19 (362)
- Cancer Recurrence (120)
- Childhood Cancer Issues (120)
- Clinical Trials (624)
- Complementary Integrative Medicine (22)
- Cytogenetics (2)
- DNA Methylation (4)
- Diagnosis (222)
- Epigenetics (6)
- Fertility (62)
- Follow-up Guidelines (2)
- Health Disparities (14)
- Hereditary Cancer Syndromes (122)
- Immunology (18)
- Li-Fraumeni Syndrome (8)
- Mental Health (116)
- Molecular Diagnostics (8)
- Pain Management (64)
- Palliative Care (8)
- Pathology (10)
- Physical Therapy (18)
- Pregnancy (18)
- Prevention (874)
- Research (402)
- Second Opinion (74)
- Sexuality (16)
- Side Effects (600)
- Sleep Disorders (10)
- Stem Cell Transplantation Cellular Therapy (216)
- Support (402)
- Survivorship (324)
- Symptoms (180)
- Treatment (1762)
Our First Full Clinical Extension Opens
BY Lori Baker
1 minute read | Published September 26, 2011
Medically Reviewed | Last reviewed by an MD Anderson Cancer Center medical professional on September 26, 2011
Banner MD Anderson Cancer Center opens its doors to patients today, Monday, Sept. 26. The center, located just outside of Phoenix, represents MD Anderson's first full clinical extension outside the Houston area.
"Today's opening is a milestone in our mission to eliminate cancer," says Ronald DePinho, M.D., president of MD Anderson.
Initially, inpatient services will be provided in 76 beds at Banner Gateway Medical Center, and outpatient services will be offered in a newly constructed, three-story facility that includes:
- 30 multispecialty clinical exam rooms
- 12 private infusion therapy rooms and 28 open infusion bays
- State-of-the-art diagnostic imaging equipment including PET- CT, MRI, and CT modalities
- Three linear accelerator vaults
- One high-dose-rate brachytherapy vault
To promote hope and healing, the facility includes a four-story Lantern of Hope, treatment rooms positioned to offer views of the desert landscape and floor-to-ceiling windows throughout that let in lots of natural light.
Banner MD Anderson opens with more than 200 employees, including physicians, nurses, radiation oncology, and other medical and support workers.
Margaret Row, M.D., associate vice president for MD Anderson's Center for Global Oncology, describes the relationship between MD Anderson and Banner Health in this video.
Related Cancerwise Stories
